home / stock / lovff / lovff quote
Last: | $0.643 |
---|---|
Change Percent: | 0.0% |
Open: | $0.643 |
Close: | $0.643 |
High: | $0.643 |
Low: | $0.643 |
Volume: | 455 |
Last Trade Date Time: | 04/12/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.643 | $0.643 | $0.643 | $0.643 | $0.643 | 455 | 04-12-2024 |
$0.68074 | $0.68074 | $0.68074 | $0.68074 | $0.68074 | 335 | 04-11-2024 |
$0.62398 | $0.6501 | $0.62398 | $0.657 | $0.62065 | 3,372 | 04-08-2024 |
$0.6529 | $0 | $0.6529 | $0 | $0 | 1,040 | 04-05-2024 |
$0.6529 | $0.68579 | $0.6529 | $0.68579 | $0.6529 | 3,710 | 04-04-2024 |
$0.6957 | $0.6957 | $0.6957 | $0.6957 | $0.6957 | 400 | 03-27-2024 |
$0.7025 | $0.7025 | $0.7025 | $0.7025 | $0.7025 | 500 | 03-26-2024 |
$0.694 | $0.694 | $0.694 | $0.694 | $0.694 | 100 | 03-25-2024 |
$0.7 | $0.7 | $0.7 | $0.7026 | $0.7 | 5,000 | 03-22-2024 |
$0.71132 | $0.71132 | $0.71132 | $0.71132 | $0.71132 | 985 | 03-21-2024 |
$0.7044 | $0 | $0.7044 | $0 | $0 | 1,095 | 03-18-2024 |
$0.7044 | $0.6844 | $0.7044 | $0.7044 | $0.6813 | 1,500 | 03-15-2024 |
$0.6844 | $0 | $0.6844 | $0 | $0 | 50 | 03-14-2024 |
$0.6844 | $0.7073 | $0.6844 | $0.7073 | $0.6844 | 3,250 | 03-13-2024 |
$0.7285 | $0.7285 | $0.7285 | $0.7285 | $0.7285 | 100 | 03-11-2024 |
$0.7213 | $0 | $0.7213 | $0 | $0 | 70 | 03-06-2024 |
$0.7213 | $0.7213 | $0.7213 | $0.7213 | $0.7213 | 2,770 | 03-05-2024 |
$0.7212 | $0.7189 | $0.7212 | $0.7212 | $0.7189 | 23,100 | 03-01-2024 |
$0.7251 | $0.74804 | $0.7251 | $0.74804 | $0.7251 | 2,838 | 02-29-2024 |
$0.687 | $0 | $0.687 | $0 | $0 | 3,500 | 02-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc Company Name:
LOVFF Stock Symbol:
OTCMKTS Market:
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion Canada NewsWire Record Q1 net revenues of $19.5 million , representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operat...
MONTREAL, Jan. 8, 2024 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a ver...